GlassScriptPhysician profile
Cecilia Pitts
NPI 1326673385
$3,234.27
in general payments reported to CMS, 2019-2025
29 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $691 · 2022: $386 · 2023: $901 · 2024: $917 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,047 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,047.16 |
| Education | $110.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $484.47 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $418.14 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $373.43 | 2021-2025 | Brilinta, Farxiga, Lokelma |
| Pfizer INC. | $282.73 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $227.43 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $166.50 | 2021-2023 | Eliquis |
| Amgen INC. | $162.69 | 2021-2024 | Repatha |
| Merck Sharp & Dohme LLC | $147.88 | 2022-2025 | Verquvo |
| Boston Scientific Corporation | $144.44 | 2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $141.91 | 2022-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $95.84 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals International, Plc | $74.05 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $62.56 | 2022-2024 | |
| Cvrx, INC. | $47.10 | 2024-2025 | Barostim Neo System |
| Novo Nordisk INC | $43.87 | 2024 | Wegovy, Rybelsus, Ozempic |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $35.03 | 2021 | |
| Medtronic, INC. | $33.02 | 2021-2024 | Linq II |
| Inspire Medical Systems, INC. | $32.16 | 2024 | Inspire |
| Edwards Lifesciences Corporation | $30.40 | 2021 | |
| Imperative Care, INC | $29.96 | 2024 | Prodigy Catheter |
| Tactile Systems Technology INC | $29.90 | 2025 | Flexitouch Plus, Nimbl |
| Daiichi Sankyo INC. | $26.76 | 2024 | Injectafer |
| United Therapeutics Corporation | $26.35 | 2025 | Tyvaso |
| Ionis Pharmaceuticals, INC. | $24.10 | 2025 | Tryngolza |
| Impulse Dynamics (USA) INC. | $23.78 | 2022 | |
| Celgene Corporation | $23.49 | 2025 | Eliquis |
| Biosense Webster, INC. | $20.87 | 2022 | |
| Silk Road Medical, INC. | $13.48 | 2021 | |
| Acutus Medical, INC. | $11.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecilia Pitts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.